BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9142204)

  • 1. Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?
    Rosenzweig KE; Arceci RJ; Tarbell NJ
    Med Pediatr Oncol; 1997 Jul; 29(1):36-40. PubMed ID: 9142204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis.
    Minehan KJ; Chen MG; Zimmerman D; Su JQ; Colby TV; Shaw EG
    Int J Radiat Oncol Biol Phys; 1992; 23(3):519-24. PubMed ID: 1612952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
    Kaltsas GA; Powles TB; Evanson J; Plowman PN; Drinkwater JE; Jenkins PJ; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1370-6. PubMed ID: 10770168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis.
    Nanduri VR; Bareille P; Pritchard J; Stanhope R
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):509-15. PubMed ID: 11012577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?
    Broadbent V; Pritchard J
    Med Pediatr Oncol; 1997 Apr; 28(4):289-93. PubMed ID: 9078326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy in soft-tissue lesions in histiocytosis X (Langerhans' cell histiocytosis).
    Gramatovici R; D'Angio GJ
    Med Pediatr Oncol; 1988; 16(4):259-62. PubMed ID: 3262194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes insipidus in Langerhans' cell histiocytosis: report of a case.
    Wu HT; Chen BH; Sheen JM; Chang TT; Ko SC
    Kaohsiung J Med Sci; 1999 May; 15(5):302-6. PubMed ID: 10375874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrinological aspects of Langerhans cell histiocytosis complicated with diabetes insipidus.
    Lin KD; Lin JD; Hsu HH; Juang JH; Huang MJ; Huang HS
    J Endocrinol Invest; 1998; 21(7):428-33. PubMed ID: 9766256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis.
    Kotecha R; Venkatramani R; Jubran RF; Arkader A; Olch AJ; Wong K
    Am J Clin Oncol; 2014 Dec; 37(6):592-6. PubMed ID: 23466581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study.
    Grois N; Flucher-Wolfram B; Heitger A; Mostbeck GH; Hofmann J; Gadner H
    Med Pediatr Oncol; 1995 Apr; 24(4):248-56. PubMed ID: 7700170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.
    Dunger DB; Broadbent V; Yeoman E; Seckl JR; Lightman SL; Grant DB; Pritchard J
    N Engl J Med; 1989 Oct; 321(17):1157-62. PubMed ID: 2797079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.
    Leger J; Velasquez A; Garel C; Hassan M; Czernichow P
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1954-60. PubMed ID: 10372693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis.
    Grois N; Prayer D; Prosch H; Minkov M; Pötschger U; Gadner H
    Pediatr Blood Cancer; 2004 Jul; 43(1):59-65. PubMed ID: 15170891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis.
    Montefusco L; Harari S; Elia D; Rossi A; Specchia C; Torre O; Adda G; Arosio M
    Eur J Intern Med; 2018 May; 51():61-67. PubMed ID: 29198444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed diagnosis of pediatric Langerhans' cell histiocytosis: case report and retrospective review of pediatric cases seen at Mayo Clinic.
    Jarquin-Valdivia AA; Buchhalter J
    J Child Neurol; 2001 Jul; 16(7):535-8. PubMed ID: 11453455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pituitary gland in patients with Langerhans cell histiocytosis: a clinical and radiological evaluation.
    Kurtulmus N; Mert M; Tanakol R; Yarman S
    Endocrine; 2015 Apr; 48(3):949-56. PubMed ID: 25209890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.
    Czernichow P; Garel C; Léger J
    Horm Res; 2000; 53 Suppl 3():61-4. PubMed ID: 10971107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
    Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of hypothalamic pituitary tumors in Langerhans cell histiocytosis.
    Fahrner B; Prosch H; Minkov M; Krischmann M; Gadner H; Prayer D; Grois N
    Pediatr Blood Cancer; 2012 Apr; 58(4):606-10. PubMed ID: 22183971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study.
    Donadieu J; Rolon MA; Thomas C; Brugieres L; Plantaz D; Emile JF; Frappaz D; David M; Brauner R; Genereau T; Debray D; Cabrol S; Barthez MA; Hoang-Xuan K; Polak M;
    J Pediatr; 2004 Mar; 144(3):344-50. PubMed ID: 15001940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.